Molecular Diagnostics Market, By Product (Reagents & Kits, Instruments & Systems, and Software & Services), By Technology, By Application, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4601
|
Published Date
December 2025
|
Pages
387
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
The Molecular Diagnostics Market size was valued at US$ 25,456.89 Million in 2024, expanding at a CAGR of 4.1% from 2025 to 2032.
The molecular diagnostics market is witnessing robust growth, driven by increasing demand for accurate, rapid, and early disease detection. Key technologies—including PCR, next-generation sequencing (NGS), in situ hybridization (ISH), microarrays, and isothermal amplification—are extensively utilized for diagnosing infectious diseases, cancers, genetic disorders, and conducting blood screening. The rising prevalence of conditions such as HIV, COVID-19, tuberculosis, and various cancers continues to fuel adoption of molecular diagnostic tests. Expanding applications in personalized medicine, companion diagnostics, and pharmacogenomics further support market growth. However, the sector faces challenges, including high costs of tests and equipment, complex regulatory approval processes, and the need for skilled personnel, which can constrain widespread adoption.
Molecular Diagnostics Market- Market Dynamics
Increasing Incidence of Infectious Diseases and Cancer
Molecular diagnostics, including PCR, real-time PCR, and isothermal amplification, enable the early detection of pathogens even at very low viral or bacterial loads. This capability facilitates timely treatment decisions, effective outbreak management, and improved patient care. The emergence of new viral variants and rising antimicrobial resistance further emphasizes the importance of molecular-level testing. The increasing prevalence of infectious diseases and cancers is a key driver of the molecular diagnostics market. Infectious conditions such as HIV, hepatitis B and C, tuberculosis, influenza, respiratory infections, and emerging viral threats require rapid, accurate, and highly sensitive detection methods. According to the World Health Organization, by the end of 2024, approximately 40.8 million people worldwide were living with HIV, including 39.4 million adults and 1.4 million children. That year, around 1.3 million individuals were newly infected, and approximately 630,000 people died from AIDS-rel—a 54% decline in AIDS-related deaths since 2010. The rising global disease burden, combined with the growing need for early diagnosis and the expansion of precision medicine applications, is significantly accelerating the adoption of molecular diagnostics across healthcare systems worldwide.
Molecular Diagnostics Market- Segmentation Analysis:
The Global Molecular Diagnostics Market is segmented on the basis of Product, Technology, Application, End User, and Region.
The global molecular diagnostics market is segmented by product into reagents & kits, instruments & systems, and software & services, with reagents and kits dominating due to the high frequency of diagnostic testing in clinical and research laboratories. Instruments and systems play a critical role in supporting automation, enhancing precision, and ensuring reproducibility across diverse molecular assays, while software and services facilitate efficient data analysis, workflow management, and integration across laboratory networks. Government investment in national diagnostic programs, including initiatives to expand laboratory capacity and enhance disease surveillance, has further driven demand for consumables, automated systems, and analytics platforms, particularly in countries prioritizing genomic medicine and public health preparedness.
By technology, the market is divided into PCR, next-generation sequencing (NGS), in situ hybridization, chips and microarrays, mass spectrometry, and other emerging diagnostic technologies. NGS has seen rapid adoption for genomic profiling and personalized medicine, with government-funded genomics projects worldwide accelerating access to sequencing platforms and bioinformatics infrastructure. In situ hybridization is increasingly applied in spatial genomics and pathology research, supported by regulatory standards and public health programs requiring accurate tissue-level diagnostics. Chips and microarrays, as well as mass spectrometry, enhance multiplexing capacity and analytical precision, facilitating large-scale screening, biomarker discovery, and clinical diagnostics. Other specialized and emerging technologies, including CRISPR-based diagnostics and advanced biosensors, are being integrated into national research agendas and funded programs to improve early disease detection and laboratory innovation
Molecular Diagnostics Market- Geographical Insights
North America continues to lead the molecular diagnostics market, driven by advanced healthcare infrastructure, widespread adoption of PCR and NGS technologies, a strong presence of leading diagnostic companies, and well-established reimbursement frameworks. Europe closely follows, supported by increasing demand for cancer diagnostics and infectious disease testing, along with government initiatives promoting precision medicine and standardized laboratory practices. The Asia-Pacific region is emerging as the fastest-growing market, fueled by expanding healthcare access, a rising burden of chronic and infectious diseases, large patient populations, and significant investments in genomics and laboratory automation, particularly in China, India, and Japan. Latin America is experiencing moderate growth, aided by expanding diagnostic capabilities and government-backed public health programs. Meanwhile, the Middle East and Africa remain developing markets, with growth constrained by cost challenges but bolstered b
Molecular Diagnostics Market- Country Insights
The United States molecular diagnostics market has been experiencing notable growth, reflecting a strong CAGR. This expansion is primarily driven by technological advancements in diagnostics, increasing demand for personalized medicine, and a rising incidence of infectious diseases and cancer. The U.S. healthcare system’s emphasis on early disease detection and precision medicine has accelerated the adoption of molecular diagnostics across hospitals, research institutions, and diagnostic laboratories. Key technologies, including liquid biopsy and next-generation sequencing (NGS), are increasingly utilized to improve diagnostic accuracy and enable targeted therapy selection, particularly in oncology. Additionally, the prevalence of infectious diseases such as COVID-19, influenza, and HIV continues to drive demand for rapid and reliable molecular testing. Globally, governments are also promoting early detection and advanced diagnostics; for example, in 2024, the World Health Organization reported that several
Molecular Diagnostics Market- Competitive Landscape:
The molecular diagnostics market in 2025 is characterized by strong competition, with leading global players driving growth through advanced product portfolios, technological innovation, and strategic expansions. For example, in August 2024, Sysmex Corporation expanded its strategic alliance with QIAGEN to strengthen collaboration in genetic testing, encompassing research and development, production, clinical trials, and global sales and marketing. This builds on their initial 2021 partnership focused on cancer companion diagnostics using highly sensitive liquid biopsy NGS technology. Key market participants also focus on regulatory approvals, acquisitions, and strategic partnerships to enhance their market presence. Continuous R&D and collaborative efforts across the industry enable the molecular diagnostics market to address diverse clinical requirements worldwide, supporting robust global growth.
Recent Developments:
- In March 2025, Danaher Corporation, through subsidiaries such as Beckman Coulter, invested in automated and high-throughput molecular diagnostic solutions to cater to various clinical needs.
- In February 2023, Becton Dickinson (BD) received FDA Emergency Use Authorization (EUA) for a molecular diagnostic test capable of detecting and differentiating COVID-19, influenza A/B, and respiratory syncytial virus (RSV). The test, designed for use with the BD MAX Molecular Diagnostic System, requires only a single nasal or nasopharyngeal swab sample.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL MOLECULAR DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- BD
- Abbott
- F. Hoffmann-La Roche, Ltd.
- Agilent Technologies, Inc.
- Danaher Corporation
- Siemens Healthineers AG
- Agilent Technologies Inc.
- Hologic Inc. (Gen Probe)
- Sysmex Corporation
- Illumina Inc.
- Others
GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032
- Reagents & Kits
- Instruments & Systems
- Software & Services
GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032
- PCR
- Next-Generation Sequencing (NGS)
- In Situ Hybridization
- Chips & Microarrays
- Mass Spectrometry
- Other Technologies
GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Oncology
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Others
- Infectious Disease
- Respiratory Infections
- Sexually Transmitted Infections
- Blood-borne Infections
- Tuberculosis & Non-tuberculous Mycobacteria
- Others
- Pharmacogenomics
- Microbiology
- Genetic Disease Screening
- Human Leukocyte Antigen Typing
- Blood Screening
- Others
GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals
- Diagnostic & Reference Laboratories
- Academic & Research Institutes
- Other End Users
GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Molecular Diagnostics Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Molecular Diagnostics Market Snippet by Product
2.1.2. Molecular Diagnostics Market Snippet by Technology
2.1.3. Molecular Diagnostics Market Snippet by Application
2.1.4. Molecular Diagnostics Market Snippet by End User
2.1.5. Molecular Diagnostics Market Snippet by Country
2.1.6. Molecular Diagnostics Market Snippet by Region
2.2. Competitive Insights
3. Molecular Diagnostics Key Market Trends
3.1. Molecular Diagnostics Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Molecular Diagnostics Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Molecular Diagnostics Market Opportunities
3.4. Molecular Diagnostics Market Future Trends
4. Molecular Diagnostics Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Molecular Diagnostics Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Molecular Diagnostics Market Landscape
6.1. Molecular Diagnostics Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Molecular Diagnostics Market – By Product
7.1. Overview
7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
7.1.2. Reagents & Kits
7.1.3. Instruments & Systems
7.1.4. Software & Services
8. Molecular Diagnostics Market – By Technology
8.1. Overview
8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
8.1.2. PCR
8.1.3. Next-Generation Sequencing (NGS)
8.1.4. In Situ Hybridization
8.1.5. Chips & Microarrays
8.1.6. Mass Spectrometry
8.1.7. Other Technologies
9. Molecular Diagnostics Market – By Application
9.1. Overview
9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
9.1.2. Oncology
9.1.2.1. Breast Cancer
9.1.2.2. Prostate Cancer
9.1.2.3. Colorectal Cancer
9.1.2.4. Others
9.1.3. Infectious Disease
9.1.3.1. Respiratory Infections
9.1.3.2. Sexually Transmitted Infections
9.1.3.3. Blood-borne Infections
9.1.3.4. Tuberculosis & Non-tuberculous Mycobacteria
9.1.3.5. Others
9.1.4. Pharmacogenomics
9.1.5. Microbiology
9.1.6. Genetic Disease Screening
9.1.7. Human Leukocyte Antigen Typing
9.1.8. Blood Screening
9.1.9. Others
10. Molecular Diagnostics Market – By End User
10.1. Overview
10.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
10.1.2. Hospitals
10.1.3. Diagnostic & Reference Laboratories
10.1.4. Academic & Research Institutes
10.1.5. Other End Users
11. Molecular Diagnostics Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
11.2. North America
11.2.1. Overview
11.2.2. Molecular Diagnostics Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Molecular Diagnostics Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.10.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.17. Rest of Europe
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.17.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.17.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.17.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Molecular Diagnostics Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.7. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.8.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.9.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Molecular Diagnostics Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Molecular Diagnostics Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.7. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- Molecular Diagnostics Industry
12.1. Competitive Dashboard
12.1.1. Competitive Benchmarking
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. BD
12.2.2. Abbott
12.2.3. F. Hoffmann-La Roche, Ltd.
12.2.4. Agilent Technologies, Inc.
12.2.5. Danaher Corporation
12.2.6. Siemens Healthineers AG
12.2.7. Agilent Technologies Inc.
12.2.8. Hologic Inc. (Gen Probe)
12.2.9. Sysmex Corporation
12.2.10. Illumina Inc.
12.2.11. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL MOLECULAR DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- BD
- Abbott
- F. Hoffmann-La Roche, Ltd.
- Agilent Technologies, Inc.
- Danaher Corporation
- Siemens Healthineers AG
- Agilent Technologies Inc.
- Hologic Inc. (Gen Probe)
- Sysmex Corporation
- Illumina Inc.
- Others
GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032
- Reagents & Kits
- Instruments & Systems
- Software & Services
GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032
- PCR
- Next-Generation Sequencing (NGS)
- In Situ Hybridization
- Chips & Microarrays
- Mass Spectrometry
- Other Technologies
GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Oncology
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Others
- Infectious Disease
- Respiratory Infections
- Sexually Transmitted Infections
- Blood-borne Infections
- Tuberculosis & Non-tuberculous Mycobacteria
- Others
- Pharmacogenomics
- Microbiology
- Genetic Disease Screening
- Human Leukocyte Antigen Typing
- Blood Screening
- Others
GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals
- Diagnostic & Reference Laboratories
- Academic & Research Institutes
- Other End Users
GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
